Evidence map›Paper›PMID 29203489›Full record

ArticleAntimicrobial agents and chemotherapy2018

Distribution and Molecular Characterization of Acinetobacter baumannii International Clone II Lineage in Japan.

Mari Matsui, Masato Suzuki, Masahiro Suzuki, Jun Yatsuyanagi, Masanori Watahiki, Yoichi Hiraki, Fumio Kawano, Atsuko Tsutsui, Keigo Shibayama, Satowa Suzuki

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Whole-genome sequencing and characterization ofFrontiers in microbiology · 2026
    Article
  4. The global epidemiology of carbapenem-resistantJAC-antimicrobial resistance · 2025
    Review
  5. Article
  6. Article
  7. The fitness connection of antibiotic resistance.Frontiers in microbiology · 2025
    Article
  8. Review
  9. Type IV Pilus-Mediated Inhibition ofMicrobiology spectrum · 2023
    Article
  10. Article
  11. Microbiology spectrum · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. The Role of Antibiotic ResistantAntibiotics (Basel, Switzerland) · 2021
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Dual infections of two carbapenemase-producingAntimicrobial resistance and infection control · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mari MatsuiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan m-matsui@niid.go.jp.
Masato SuzukiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Masahiro SuzukiLaboratory of Bacteriology, Aichi Prefectural Institute of Public Health, Nagoya, Japan.
Jun YatsuyanagiAkita Prefectural Institute of Public Health, Akita, Japan.
Masanori WatahikiDepartment of Bacteriology, Toyama Institute of Health, Toyama, Japan.
Yoichi HirakiDepartment of Infection Control Unit, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Fumio KawanoDepartment of Infection Control Unit, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Atsuko TsutsuiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Keigo ShibayamaAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Satowa SuzukiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant (MDR)

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsDrug Resistance, Multiple, BacterialHumansJapanMicrobial Sensitivity TestsMolecular EpidemiologyAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsAcinetobacter baumannii international clone IIAcinetobacter spp.blaADCMLST

Identifiers

PMID29203489
PMCPMC5786803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.